Literature DB >> 29601864

TMEM2: A missing link in hyaluronan catabolism identified?

Yu Yamaguchi1, Hayato Yamamoto2, Yuki Tobisawa2, Fumitoshi Irie2.   

Abstract

Hyaluronan (HA) is a glycosaminoglycan (GAG) composed of repeating disaccharide units of glucuronic acid and N-acetylglucosamine. HA is an extremely long, unbranched polymer, which often exceeds 106 Da and sometimes reaches 107 Da. A feature that epitomizes HA is its rapid turnover; one-third of the total body HA is turned over daily. The current model of HA catabolism postulates that high-molecular weight HA in the extracellular space is first cleaved into smaller fragments by a hyaluronidase(s) that resides at the cell surface, followed by internalization of fragments and their degradation into monosaccharides in lysosomes. Over the last decade, considerable research has shown that the HYAL family of hyaluronidases plays significant roles in HA catabolism. Nonetheless, the identity of a hyaluronidase responsible for the initial step of HA cleavage on the cell surface remains elusive, as biochemical and enzymological properties of HYAL proteins are not entirely consistent with those expected of cell surface hyaluronidases. Recent identification of transmembrane 2 (TMEM2) as a cell surface protein that possesses potent hyaluronidase activity suggests that it may be the "missing" cell surface hyaluronidase, and that novel models of HA catabolism should include this protein.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29601864      PMCID: PMC6314907          DOI: 10.1016/j.matbio.2018.03.020

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  63 in total

Review 1.  Hyal2--less active, but more versatile?

Authors:  G Lepperdinger; J Müllegger; G Kreil
Journal:  Matrix Biol       Date:  2001-12       Impact factor: 11.583

2.  Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme.

Authors:  T D Camenisch; A P Spicer; T Brehm-Gibson; J Biesterfeldt; M L Augustine; A Calabro; S Kubalak; S E Klewer; J A McDonald
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.

Authors:  Christopher J Ward; Marie C Hogan; Sandro Rossetti; Denise Walker; Tam Sneddon; Xiaofang Wang; Vicky Kubly; Julie M Cunningham; Robert Bacallao; Masahiko Ishibashi; Dawn S Milliner; Vicente E Torres; Peter C Harris
Journal:  Nat Genet       Date:  2002-02-04       Impact factor: 38.330

Review 4.  The six hyaluronidase-like genes in the human and mouse genomes.

Authors:  A B Csoka; G I Frost; R Stern
Journal:  Matrix Biol       Date:  2001-12       Impact factor: 11.583

Review 5.  The dual functions of GPI-anchored PH-20: hyaluronidase and intracellular signaling.

Authors:  G N Cherr; A I Yudin; J W Overstreet
Journal:  Matrix Biol       Date:  2001-12       Impact factor: 11.583

6.  Structure of a plant cell wall fragment complexed to pectate lyase C.

Authors:  R D Scavetta; S R Herron; A T Hotchkiss; N Kita; N T Keen; J A Benen; H C Kester; J Visser; F Jurnak
Journal:  Plant Cell       Date:  1999-06       Impact factor: 11.277

7.  Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation.

Authors:  S K Rai; F M Duh; V Vigdorovich; A Danilkovitch-Miagkova; M I Lerman; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

8.  Mutations in HYAL1, a member of a tandemly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX.

Authors:  B Triggs-Raine; T J Salo; H Zhang; B A Wicklow; M R Natowicz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

9.  Crystal structure of chondroitinase B from Flavobacterium heparinum and its complex with a disaccharide product at 1.7 A resolution.

Authors:  W Huang; A Matte; Y Li; Y S Kim; R J Linhardt; H Su; M Cygler
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

10.  Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling.

Authors:  B G Gálvez; S Matías-Román; J P Albar; F Sánchez-Madrid; A G Arroyo
Journal:  J Biol Chem       Date:  2001-07-11       Impact factor: 5.157

View more
  20 in total

1.  Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis.

Authors:  Yoon Mee Yang; Mazen Noureddin; Cheng Liu; Koichiro Ohashi; So Yeon Kim; Divya Ramnath; Elizabeth E Powell; Matthew J Sweet; Yoon Seok Roh; I-Fang Hsin; Nan Deng; Zhenqiu Liu; Jiurong Liang; Edward Mena; Daniel Shouhed; Robert F Schwabe; Dianhua Jiang; Shelly C Lu; Paul W Noble; Ekihiro Seki
Journal:  Sci Transl Med       Date:  2019-06-12       Impact factor: 17.956

2.  Cardiac mesenchymal cells from failing and nonfailing hearts limit ventricular dilation when administered late after infarction.

Authors:  Timothy N Audam; Yibing Nong; Alex Tomlin; Andrea Jurkovic; Hong Li; Xiaoping Zhu; Bethany W Long; Yi Wei Zheng; Tyler Weirick; Kenneth R Brittian; Daniel W Riggs; Anna Gumpert; Shizuka Uchida; Yiru Guo; Marcin Wysoczynski; Steven P Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-22       Impact factor: 4.733

Review 3.  The matrix in cancer.

Authors:  Thomas R Cox
Journal:  Nat Rev Cancer       Date:  2021-02-15       Impact factor: 60.716

Review 4.  Proteoglycans in Toll-like receptor responses and innate immunity.

Authors:  Stavros Garantziotis; Rashmin C Savani
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-08       Impact factor: 5.282

5.  Crosstalk between CD4 T cells and synovial fibroblasts from human arthritic joints promotes hyaluronan-dependent leukocyte adhesion and inflammatory cytokine expression in vitro.

Authors:  Inkyung Kang; Christian Hundhausen; Stephen P Evanko; Prasanthi Malapati; Gail Workman; Christina K Chan; Cliff Rims; Gary S Firestein; David L Boyle; Kevin M MacDonald; Jane H Buckner; Thomas N Wight
Journal:  Matrix Biol Plus       Date:  2022-04-26

6.  Possible Repositioning of an Oral Anti-Osteoporotic Drug, Ipriflavone, for Treatment of Inflammatory Arthritis via Inhibitory Activity of KIAA1199, a Novel Potent Hyaluronidase.

Authors:  Hiroshi Koike; Yoshihiro Nishida; Tamayuki Shinomura; Bisei Ohkawara; Kinji Ohno; Lisheng Zhuo; Koji Kimata; Takahiro Ushida; Shiro Imagama
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

Review 7.  Narrative review of urinary glycan biomarkers in prostate cancer.

Authors:  Shingo Hatakeyama; Tohru Yoneyama; Yuki Tobisawa; Hayato Yamamoto; Chikara Ohyama
Journal:  Transl Androl Urol       Date:  2021-04

8.  Transcriptome Analysis of Hypoxic Lymphatic Endothelial Cells Indicates Their Potential to Contribute to Extracellular Matrix Rearrangement.

Authors:  Jürgen Becker; Sonja Schwoch; Christina Zelent; Maren Sitte; Gabriela Salinas; Jörg Wilting
Journal:  Cells       Date:  2021-04-24       Impact factor: 6.600

Review 9.  Modulation of hyaluronan signaling as a therapeutic target in human disease.

Authors:  Stavros Garantziotis
Journal:  Pharmacol Ther       Date:  2021-09-26       Impact factor: 12.310

Review 10.  The role of hyaluronan synthesis and degradation in the critical respiratory illness COVID-19.

Authors:  Nansy Albtoush; Aaron C Petrey
Journal:  Am J Physiol Cell Physiol       Date:  2022-04-20       Impact factor: 5.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.